钙与维生素D降低甲状腺切除术后甲状旁腺功能减退及住院时间:一项随机对照试验
这项单中心前瞻性随机对照开放标签试验纳入600例行全甲状腺切除术且未行中央区颈淋巴结清扫的患者,比较预防性口服钙剂联合阿法骨化醇与标准术后护理。结果显示预防性补充显著降低实验室及症状性低钙血症和静脉补钙需求,并缩短住院时间。
要点
- 预防性补钙联合阿法骨化醇可显著降低全甲状腺切除术后实验室低钙血症发生率。
- 症状性低钙血症和静脉补钙需求在补充组也显著降低。
- 补充组术后第1、2天血钙更高,住院时间更短。
核心结论
- 全甲状腺切除术后常规补充钙和维生素D可显著减少短暂性甲状旁腺功能减退并缩短住院时间,支持其作为标准术后策略。
研究设计与样本
- 单中心、前瞻性、随机、对照、开放标签试验,共600例行全甲状腺切除术且未行中央区颈淋巴结清扫的患者,随机分为预防性口服钙碳酸盐/葡萄糖酸盐联合阿法骨化醇组(A组,n=300)或标准术后护理组(B组,n=300)。
主要发现
- A组实验室低钙血症(血清钙<8.5 mg/dL)发生率为16.9%,B组为39.9%(OR 0.305,95%CI 0.207-0.451,P<.001)。
- A组症状性低钙血症发生率为5.6%,B组为12.3%(OR 0.427,95%CI 0.232-0.785,P<.005)。
- A组需静脉补钙比例为1.8%,B组为9.3%(OR 0.175,95%CI 0.070-0.441,P<.001)。
- A组术后第1天和第2天平均血清钙水平更高(P<.001),住院时间更短(1.25天 vs 1.7天,P<.001)。
- 按恶性肿瘤状态和术前维生素D水平分层的亚组中,补充获益一致。
关键数值与推荐
- 预防性口服钙碳酸盐/葡萄糖酸盐联合阿法骨化醇用于全甲状腺切除术后患者。
- 实验室低钙血症定义为血清钙<8.5 mg/dL。
临床怎么用
- 全甲状腺切除术后可考虑常规预防性口服钙剂联合阿法骨化醇,以降低低钙血症风险并缩短住院时间。
- 对未行中央区颈淋巴结清扫的患者,该策略的获益在恶性肿瘤状态和术前维生素D水平亚组中一致。
局限性
- 单中心、开放标签设计可能引入偏倚。
- 研究仅纳入未行中央区颈淋巴结清扫的全甲状腺切除术患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transient hypoparathyroidism is a common complication after total thyroidectomy, prolonging hospitalization and necessitating calcium and/or vitamin D replacement. Evidence from prospective randomized trials on preventive supplementation remains limited. This study aimed to evaluate whether prophylactic calcium and vitamin D supplementation reduces transient hypoparathyroidism and shortens hospital stay after total thyroidectomy. METHODS: In this single-center, prospective, randomized, controlled, open-label trial, 600 patients undergoing total thyroidectomy without central neck dissection were randomized to receive prophylactic oral calcium carbonate/gluconate and alfacalcidol (group A, n = 300) or standard postoperative care (group B, n = 300). Primary outcomes were biochemical and symptomatic hypocalcemia and the need for intravenous calcium. Secondary outcomes included postoperative serum calcium levels and length of hospital stay. Statistical analyses used χ2, Student's t test, Mann-Whitney U test, and odds ratio and 95% confidence interval. RESULTS: Laboratory hypocalcemia (serum calcium <8.5 mg/dL) occurred significantly less often in group A (16.9% vs 39.9%; odds ratio 0.305, 95% confidence interval 0.207-0.451, P < .001). Symptomatic hypocalcemia was also reduced (5.6% vs 12.3%; odds ratio 0.427, 95% confidence interval 0.232-0.785, P < .005), as was the need for intravenous calcium (1.8% vs 9.3%; odds ratio 0.175, 95% confidence interval 0.070-0.441, P < .001). Group A demonstrated higher mean serum calcium levels on postoperative days 1 and 2 (P < .001) and a shorter hospital stay (1.25 days vs 1.7 days, P < .001). Supplementation benefits were consistent across subgroups stratified by malignancy status and preoperative vitamin D levels. CONCLUSION: Routine calcium and vitamin D supplementation after total thyroidectomy significantly reduces transient hypoparathyroidism and shortens hospitalization. These findings support its use as a standard postoperative strategy to enhance recovery and reduce health care resource utilization.
引用
- Gkanis V, Nastos K, Ntalaperas K, et al. Calcium and vitamin D reduce hypoparathyroidism and hospital stay after thyroidectomy: A randomized controlled trial. Surgery. 2026. PMID: 41604835. doi:10.1016/j.surg.2025.110071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。